Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19
Yulin Zou, Zudong Meng Department of Dermatology, Renmin Hospital, Hubei University of Medicine, Shiyan City, People’s Republic of ChinaCorrespondence: Zudong Meng Email zylmch1007@hbmu.edu.cnAbstract: The COVID-19 pandemic has posed a serious problem for drug anti-viral efficacy in combat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2021-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_c17d6b59e6564653a2e5d1bde94e5ef0 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Zou Y |e author |
| 700 | 1 | 0 | |a Meng Z |e author |
| 245 | 0 | 0 | |a Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19 |
| 260 | |b Dove Medical Press, |c 2021-11-01T00:00:00Z. | ||
| 500 | |a 1178-7031 | ||
| 520 | |a Yulin Zou, Zudong Meng Department of Dermatology, Renmin Hospital, Hubei University of Medicine, Shiyan City, People’s Republic of ChinaCorrespondence: Zudong Meng Email zylmch1007@hbmu.edu.cnAbstract: The COVID-19 pandemic has posed a serious problem for drug anti-viral efficacy in combatting the cytokine storm triggered by SARS-CoV-2. From dermato-epidemiological studies conducted on psoriatic and other rheumatological patients, IL-17 inhibitors seem to attenuate or even prevent the cytokine storm and thus ICU referral. Furthermore, both in-vivo and in-vitro experiments suggest that IL-17 plays a key role in SARS-CoV-2 infection progression. Due to this evidence, we decided to summarize the literature findings on IL-17 inhibitors and COVID-19, maintaining psoriasis as the referral disease to better understand the extent of drug effects on the immune system.Keywords: biologics, COVID-19, psoriasis, therapy, IL-17 | ||
| 546 | |a EN | ||
| 690 | |a biologics | ||
| 690 | |a covid-19 | ||
| 690 | |a psoriasis | ||
| 690 | |a therapy | ||
| 690 | |a il-17 | ||
| 690 | |a Pathology | ||
| 690 | |a RB1-214 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Inflammation Research, Vol Volume 14, Pp 5611-5618 (2021) | |
| 787 | 0 | |n https://www.dovepress.com/literature-overview-of-the-il-17-inhibition-from-psoriasis-to-covid-19-peer-reviewed-fulltext-article-JIR | |
| 787 | 0 | |n https://doaj.org/toc/1178-7031 | |
| 856 | 4 | 1 | |u https://doaj.org/article/c17d6b59e6564653a2e5d1bde94e5ef0 |z Connect to this object online. |